GlassScriptPhysician profile
Kevin Hsu
NPI 1477740751
$1,505.04
in general payments reported to CMS, 2019-2025
13 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $68.55 · 2021: $269 · 2022: $229 · 2024: $669 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $379.13 | 2024 | Vanta Adaptivestim, Intellis Adaptivestim |
| Boston Scientific Corporation | $251.87 | 2020-2024 | |
| Spr Therapeutics, INC | $178.17 | 2022 | |
| Abbott Laboratories | $129.98 | 2020-2024 | Proclaim |
| Biotronik Nro, INC. | $128.04 | 2024 | Prospera |
| Depuy Synthes Sales INC. | $126.07 | 2019-2021 | |
| Novo Nordisk INC | $122.87 | 2025 | Wegovy |
| Vertos Medical, INC. | $87.34 | 2024 | Mild Device Kit |
| Nevro Corp. | $38.33 | 2019-2024 | Senza |
| Bioventus LLC | $23.03 | 2022 | |
| Horizon Therapeutics Plc | $23.02 | 2019 | |
| Pacira Therapeutics, INC. | $14.13 | 2019 | |
| Si-Bone, INC. | $3.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.